Johnson & Johnson buy gerihouse
Summary
This prediction ended on 06.11.12 with a price of €55.55. With a performance of 5.59%, the BUY prediction by gerihouse for Johnson & Johnson closed with a slight gain. gerihouse has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. gerihouse has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 0.956% | 0.956% | -1.421% | 5.442% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by gerihouse for this prediction
In the thread Johnson & Johnson diskutieren
Gutes Quartalsergebnis geplant
Johnson & Johnson hat die Gewinnschätzungen in jedem der letzten vier Quartale mit einem abschließenden Vier-Quartals-Durchschnitt von 1,68% übertroffen. Ergebnisse des dritten Quartals konnte die Schätzung von 1,67% überschreiten.
Current prediction by gerihouse for Johnson & Johnson
Stopped prediction by gerihouse for Johnson & Johnson
Johnson & Johnson
05.08.22
05.08.23
06.08.23
Johnson & Johnson
08.07.21
08.07.22
08.07.22
Johnson & Johnson
09.09.20
04.11.21
12.02.21
Johnson & Johnson
28.08.19
14.04.20
14.04.20
Johnson & Johnson
18.07.17
08.12.17
08.12.17
Johnson & Johnson
19.04.17
26.06.17
26.06.17
Johnson & Johnson
21.09.15
01.12.15
01.12.15